✦ LIBER ✦

Cost effectiveness of imatinib compared with interferon-α or hydroxycarbamide for first-line treatment of chronic myeloid leukaemia

✍ Scribed by K. Dalziel; A. Round; R. Garside; K. Stein

Book ID: 126318448
Publisher: Springer International Publishing AG
Year: 2005
Tongue: English
Weight: 171 KB
Volume: 23
Category: Article
ISSN: 1170-7690
DOI: 10.2165/00019053-200523050-00010

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN2 COST-EFFECTIVENESS OF IMATINIB (GLE

PCN2 COST-EFFECTIVENESS OF IMATINIB (GLEEVEC)AS FIRST-LINE TREATMENT IN CHRONIC MYELOID LEUKEMIA (CML)

✍ K El Ouagari; W Talbot; JF Baladi 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB

First line treatment of chronic phase ch

First line treatment of chronic phase chronic myeloid leukaemia patients with the generic formulations of imatinib mesylate

✍ Eskazan, Ahmet Emre; Ayer, Mesut; Kantarcioglu, Bulent; Arica, Deniz; Demirel, N 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 55 KB

Interferon-α for the treatment of elderl

Interferon-α for the treatment of elderly patients with chronic myeloid leukaemia

✍ Wolfgang Hilbe; Ute Apfelbeck; Michael Fridrik; Marianne Bernhart; Herwig Niessn 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 79 KB

PCHI4: MEDICAL TREATMENT FOR CHRONIC MYE

PCHI4: MEDICAL TREATMENT FOR CHRONIC MYELOID LEUKAEMIA (CML):AVERAGE COST EFFECTIVENESS RATIOS OF FIRST AND SECOND LINE TREATMENT

✍ MT Groot; GJ Ossenkoppele; MHH Kramer; G van den Boom; PC Huijgens; CA Uyl-de Gr 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB

The cost-effectiveness of lamivudine com

The cost-effectiveness of lamivudine compared with interferon-α for the treatment of chronic hepatitis B

✍ Theodore Dickens; Ralph Raasch H; Gauri Saal B; Yu Yeh-Chen 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 42 KB

Cost-effectiveness of imatinib versus in

Cost-effectiveness of imatinib versus interferon-α plus low-dose cytarabine for patients with newly diagnosed chronic-phase chronic myeloid leukemia

✍ Shelby D. Reed; Kevin J. Anstrom; Jennifer A. Ludmer; G. Alastair Glendenning; K 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 119 KB 👁 1 views

## Abstract ## BACKGROUND Despite a lack of long‐term data, imatinib has become standard therapy for patients with newly diagnosed chronic‐phase chronic myeloid leukemia (CML) who are not candidates for allogeneic stem cell transplantation. In the current study, the authors estimated the increment